Navigation Links
High-Dose Flu Vaccine May Better Protect the Elderly: Study

HealthDay Reporter

WEDNESDAY, Aug. 13, 2014 (HealthDay News) -- The high-dose flu shot protects seniors better than the standard dose does, a new study finds.

About one in four cases of flu in older patients vaccinated with the standard dose could be prevented if the high-dose vaccine were used instead, the researchers reported.

"The study demonstrated a 24 percent reduction in influenza illness among the participants who received the high-dose vaccine compared to those who received the standard dose," said study co-author Dr. David Greenberg, vice president for scientific and medical affairs and chief medical officer for Sanofi Pasteur U.S., the maker of the Fluzone High-Dose vaccine and funder of the trial.

This protection is over and above the protection one gets from the standard flu shot, Greenberg noted.

He pointed out that the added protection is essential for older people. "People 65 and older account for about 60 percent of hospitalizations due to flu and about 90 percent of deaths that are flu-related," he said.

Older people tend to have weaker immune systems and don't respond as well to the standard flu shot, Greenberg explained. The high-dose vaccine was designed to address these weaknesses, he said.

Fluzone High-Dose vaccine is an inactivated influenza vaccine containing four times the vaccine found in the standard dose, Greenberg explained.

Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City, said he recommends the high-dose vaccine for his older patients. "People 65 and older do not process vaccines as well as younger people," he explained.

"Protection from the flu vaccine is not 100 percent -- it's about 60 percent effective," Horovitz said. "But if you can increase it by 15 or 20 percent, that's something."

Dr. Ambreen Khalil, an infectious diseases specialist at Staten Island University Hospital in New York City, said she is also inclined to give the high-dose vaccine to her older patients.

"We did have a lot of vaccine failure this year. A lot of patients got sick even after taking the vaccine, so if we can do something better for these patients then I would consider doing that for my patients," Khalil said.

Fluzone High-Dose is approved for people 65 and older, but is not recommended for people who have had a severe reaction to the flu vaccine in the past, according to the U.S. Centers for Disease Control and Prevention.

The CDC does not specifically recommend Fluzone High-Dose for all seniors. Rather, the agency recommends "flu vaccination as the first and most important step in protecting against flu viruses."

The report was published Aug. 14 in the New England Journal of Medicine.

For the study, researchers randomly assigned nearly 32,000 men and women aged 65 and older to receive either the high-dose flu shot or a regular dose.

Greenberg and his colleagues found that people given the high-dose shot produced more antibodies against the flu than those given the standard dose.

Greenberg also noted that the high-dose vaccine may help prevent hospitalizations, pneumonia, heart and lung problems, doctor visits and medication use.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on the flu.

SOURCES: David Greenberg, M.D., vice president, scientific and medical affairs, and chief medical officer, Sanofi Pasteur U.S., Swiftwater, Penn.; Len Horovitz, M.D., pulmonary specialist, Lenox Hill Hospital, New York City; Ambreen Khalil, M.D., infectious diseases specialist, Staten Island University Hospital, New York City; Aug. 14, 2014, New England Journal of Medicine

Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. High-dose fluticasone effective against eosinophilic esophagitis
2. Predicting outcome for high-dose IL-2 therapy in cancer patients
3. Reducing Unnecessary and High-dose Pediatric CT Scans Could Cut Associated Cancers by 62 Percent
4. High-Dose Statins Linked to Acute Kidney Damage
5. High-dose Vorinostat effective at treating relapsed lymphomas
6. Controlling spine metastases with tumor separation surgery and high-dose stereotactic radiosurgery
7. Microvax cancer vaccine first in human clinical trial in Singapore
8. HPV vaccine could close the gap on Indigenous health
9. MicroVAX Cancer Vaccine First in Human Clinical Trial in Singapore
10. Ebola Vaccine Trials Set to Begin in September
11. A vaccine alternative protects mice against malaria
Post Your Comments:
Related Image:
High-Dose Flu Vaccine May Better Protect the Elderly: Study 
(Date:11/30/2015)... Caicos Islands, BWI (PRWEB) , ... December 01, 2015 , ... ... Recently Caribbean Journal, one of the leading digital news sites highlighting Caribbean destinations, ... reason? The weather. While much of North America shivers under chilly grey skies ...
(Date:11/30/2015)... ... December 01, 2015 , ... ... carrier to offer individual vision insurance plans on . The multi-carrier ... to rate and review products, allowing consumers to compare, quote and match plans ...
(Date:11/30/2015)... ... 30, 2015 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase awareness of the ... Mouth?” campaign to inform dentists that the technicians they trust could lack the ...
(Date:11/30/2015)... ... November 30, 2015 , ... The world of hair transplants and restoration ... extraction. These techniques and procedures have been in use for many years and are ... Dr. Parsa Mohebi, M.D. has utilized many of these methods over the years, he ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... annual fundraising campaign to raise funds for its research, education, support, and advocacy ... the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Research and Markets ( ) has ... Treatment Market 2015-2019" report to their offering. ... to the report, the prevalence of mouth ulcers is ... by them. The factors contributing to this increase include ... disorders are also common among the aging population. ...
(Date:11/30/2015)... Dec. 1, 2015 Express Scripts (NASDAQ: ESRX ... IMMY ) to drive access to a low-cost alternative ... of toxoplasmosis that has been recently priced out of reach ... immune systems. --> --> ... leucovorin (a form of folic acid) for $1 per capsule for ...
(Date:11/30/2015)... TOKYO , Nov. 30, 2015 MEDTEC Japan 2016, ... and Manufacturing industry, is to be held in Tokyo from 20 th  - 22 ... --> -->   --> ...   the United States . With the aging population ... markets continuing to grow steadily. --> the United States ...
Breaking Medicine Technology: